Clinical use and the Italian demand for antithrombin

Blood Transfusion

Volumn 11, Issue SUPPL. 4, 2013, Pages

  Liumbruno, Giancarlo M ^a   Franchini, Massimo ^b   Lanzoni, Monica ^c,d   Candura, Fabio ^c   Vaglio, Stefania ^c,e   Profili, Samantha ^c   Catalano, Liviana ^c   Facco, Giuseppina ^c,f   Pupella, Simonetta ^c   Calizzani, Gabriele ^c   Grazzini, Giuliano ^c  

^a SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Azienda Ospedaliera Città della Salute e della Scienza   (Italy)

Author keywords

Analysis of demand; Antithrombin; Antithrombin deficiency; Disseminated intravascular coagulation; Plasma derived medicinal product

Indexed keywords

ANBINEX; ANTITHROMBIN; ANTITHROMBIN III; ANTITHROMBIN III CONCENTRATE; UNCLASSIFIED DRUG;

ANTITHROMBIN DEFICIENCY; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG INDICATION; DRUG USE; HIGH RISK PATIENT; HUMAN; ITALY; PRACTICE GUIDELINE; REVIEW; SEPSIS; SEPTIC SHOCK;

ANTITHROMBINS; HUMANS; ITALY;

EID: 84885627979     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.014s     Document Type: Review

References (37)

1. Hathaway WE, Goodnight SH Jr. Malattie dell'Emostasi e Trombosi. Milan: McGraw-Hill Companies Italia; 1994.
2. Bauer KA. Selective inhibition of coagulation factors: advances in antithrombotic therapy. Semin Thromb Hemost 2002; 28 (Suppl 2): 15-24. (Pubitemid 34634350)
3. Roemisch J, Gray E, Hoffmann JN, et al. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis 2002; 13: 657-70. (Pubitemid 36026822)
4. Haemostasis and Thrombosis Task Force, British Committee for Standards in Haemathology. Investigation and management of heritable thrombophilia. Br J Haematol 2001; 114: 512-28.
5. Azhar A, Singh P, Rashid Q, et al. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins. Protein Pept Lett 2013; 20: 403-11.
6. Liumbruno G, Bennardello F, Lattanzio A, et al; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party. Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates. Blood Transfus 2009; 7: 325-34.
7. Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia 2008; 14: 1229-39.
8. Lane DA, Bayston T, Olds RJ, et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197-211. (Pubitemid 27064991)
9. Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med 2002; 126: 1326-36. (Pubitemid 36237283)
10. th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl 2): e691S-736S.
11. Robertson L, Wu O, Langhorne P, et al; Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2005; 132: 171-96.
12. Friederich PW, Sanson BJ, Simioni P, et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Ann Intern Med 1996; 125: 955-60. (Pubitemid 26424523)
13. Rodgers GM. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Thromb Haemost 2009; 101: 806-12.
14. Sharpe CJ, Crowther MA, Webert KE, Donnery C. Cerebral venous thrombosis during pregnancy in the setting of type I antithrombin deficiency: case report and literature review. Transfus Med Rev 2011; 25: 61-5.
15. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009; 145: 24-33.
16. Di Nisio M, Baudo F, Cosmi B, et al; Italian Society for Thrombosis and Haemostasis. Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2012; 129: e177-84.
17. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165-228.
18. Bassler D, Millar D, Schmidt B. Antithrombin for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2006; 4: CD005383.
19. Bassler D, Schmidt B. Antithrombin replacement in neonates: is there any indication? Thromb Res 2006; 118: 107-11.
20. Afshari A, Wetterslev J, Brok J, Møller AM. Antithrombin III for critically ill patients. Cochrane Database Syst Rev 2008; 3: CD005370.
21. Martí-Carvajal AJ, Comunián-Carrasco G, Peña-Martí GE. Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum. Cochrane Database Syst Rev 2011; 3: CD008577.
22. Di Nisio M, Porreca E, Ferrante N, et al. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database Syst Rev 2012; 2: CD008500.
23. Mitchell L, Andrew M, Hanna K, et al. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Thromb Haemost 2003; 90: 235-44. (Pubitemid 36992499)
24. Truelove E, Fielding AK, Hunt BJ. The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia. Leukemia 2013; 27: 553-9.
25. Spiess BD. Treating heparin resistance with antithrombin or fresh frozen plasma. Ann Thorac Surg 2008; 85: 2153-60. (Pubitemid 351685591)
26. Finley A, Greenberg C. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg 2013; 116: 1210-22.
27. Glassock RJ: Prophylactic anticoagulation in nephrotic syndrome: A clinical conundrum. J AmSocNephrol 2007; 18: 2221-5. (Pubitemid 47203835)
28. Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol 2012; 7: 513-20.
29. Vamvakas EC. Reasons for moving toward a patientcentric paradigm of clinical transfusion medicine practice. Transfusion 2013; 53: 888-901.
30. Calizzani G, Lanzoni M, Candura F, et al. Analisi della Domanda dei Principali Medicinali Plasmaderivati in Italia. Anni 2007-2011. Roma: Istituto Superiore di Sanità 2012. (Rapporti ISTISAN 12/53). Available at: http://www.iss.it/binary/publ/cont/dodici53web.pdf. Accessed on 24/08/2013.
31. Lanzoni M, Biffoli C, Candura F, et al. Plasma-derived medicinal products in Italy: information sources and flows. Blood Transfus 2013; 11 (Suppl 4): s13-7.
32. Robert P; The Marketing Research Bureau (MRB). The Worldwide Plasma Fractions Market 2008. April 2010 Ed. Orange, CT: The Marketing Research Bureau, Inc.; 2010.
33. Wada H, Asakura H, Okamoto K, et al; Japanese Society of Thrombosis Hemostasis/DIC subcommittee. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res 2010; 125: 6-11.
34. Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost 2013; DOI 10.1111/jth.12155.
35. Iba T, Nagaoka I, Boulat M. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation. Thromb Res 2013; 131: 383-9.
36. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270-382.
37. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-82.